AL HB646

Creates a program authorizing laypersons to stock, provide, and administer epinephrine auto-injectors to individuals experiencing anaphylaxis at authorized entities such as recreation camps, colleges, day care facilities, amusement parks, and restaurants.

Allows medical practitioners to prescribe epinephrine auto-injectors in the name of authorized entities, with prescriptions valid for two years, and permits pharmacists and medical providers to dispense them pursuant to such prescriptions.

Requires employees and agents of authorized entities to complete initial anaphylaxis training and refresher training every two years, covering recognition of severe allergic reactions, storage and administration procedures, and emergency follow-up.

Establishes Emergency Public Access Stations (EPAS) as locked containers storing epinephrine auto-injectors under medical oversight, allowing lay rescuers to consult with medical practitioners in real time and obtain authorization to access the injectors.

Grants immunity from liability for authorized entities, medical practitioners, pharmacists, trainers, and EPAS users for dispensing or administering epinephrine auto-injectors in good faith, except for unreasonable, reckless, willful, or wanton conduct.